{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T16:19:43Z","timestamp":1784650783379,"version":"3.55.0"},"reference-count":30,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T00:00:00Z","timestamp":1651449600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013093","name":"AbbVie GK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013093","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Medical Economics"],"published-print":{"date-parts":[[2022,12,31]]},"DOI":"10.1080\/13696998.2022.2062951","type":"journal-article","created":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T07:41:32Z","timestamp":1649749292000},"page":"552-560","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":3,"title":["The relationship between cost and the recommendation, refusal, and discontinuation of treatment for chronic myeloid leukemia and multiple myeloma in Japan: a cross-sectional exploratory survey"],"prefix":"10.1080","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8673-0412","authenticated-orcid":false,"given":"Taro","family":"Munakata","sequence":"first","affiliation":[{"name":"Market Access, AbbVie GK, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7800-3258","authenticated-orcid":false,"given":"Yutaka","family":"Handa","sequence":"additional","affiliation":[{"name":"Medical, AbbVie GK, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8811-662X","authenticated-orcid":false,"given":"Toru","family":"Mizuno","sequence":"additional","affiliation":[{"name":"Medical, AbbVie GK, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8708-8882","authenticated-orcid":false,"given":"Nobuko","family":"Tomiuchi","sequence":"additional","affiliation":[{"name":"Medical Solutions, INTAGE Healthcare Inc., Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2389-8218","authenticated-orcid":false,"given":"Michael","family":"LoPresti","sequence":"additional","affiliation":[{"name":"Health Economics and Outcomes Research, INTAGE Healthcare Inc., Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9078-0968","authenticated-orcid":false,"given":"Junichi","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Medical, AbbVie GK, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2022,5,2]]},"reference":[{"key":"e_1_3_2_2_1","volume-title":"Cancer statistics in Japan","author":"Center for Cancer Control and Information Services, National Cancer Center","year":"2018","unstructured":"Center for Cancer Control and Information Services, National Cancer Center. Cancer statistics in Japan. Tokyo: Center for Cancer Control and Information Services, National Cancer Center; 2018."},{"key":"e_1_3_2_3_1","volume-title":"Cancer statistics in Japan","author":"Center for Cancer Control and Information Services, National Cancer Center","year":"2013","unstructured":"Center for Cancer Control and Information Services, National Cancer Center. Cancer statistics in Japan. Tokyo: Center for Cancer Control and Information Services, National Cancer Center; 2013."},{"key":"e_1_3_2_4_1","volume-title":"DI track","author":"INTAGE Healthcare","year":"2019","unstructured":"INTAGE Healthcare. DI track. Tokyo: INTAGE Healthcare Inc.; 2019."},{"key":"e_1_3_2_5_1","volume-title":"IQVIA pharmaceutical market statistics sales data period: 1989\u20132018","author":"IQVIA","year":"2019","unstructured":"IQVIA. IQVIA pharmaceutical market statistics sales data period: 1989\u20132018 (in Japanese). Tokyo: IQVIA; 2019."},{"key":"e_1_3_2_6_1","volume-title":"IQVIA pharmaceutical market statistics sales data period: January \u2013 December, 2019","author":"IQVIA.","year":"2020","unstructured":"IQVIA. IQVIA pharmaceutical market statistics sales data period: January \u2013 December, 2019 (in Japanese). Tokyo: IQVIA; 2020."},{"key":"e_1_3_2_7_1","volume-title":"Annual report on national accounts of 2019","author":"Economic and Social Research Institute","year":"2019","unstructured":"Economic and Social Research Institute. Annual report on national accounts of 2019 (in Japanese). Tokyo: Economic and Social Research Institute; 2019."},{"key":"e_1_3_2_8_1","volume-title":"Overview of medical service regime in Japan","author":"Ministry of Health, Labor, and Welfare.","year":"2021","unstructured":"Ministry of Health, Labor, and Welfare. Overview of medical service regime in Japan. Tokyo: Ministry of Health, Labor, and Welfare; 2021."},{"key":"e_1_3_2_9_1","volume-title":"Overview for those using high cost medical care","author":"Ministry of Health, Labor, and Welfare.","year":"2018","unstructured":"Ministry of Health, Labor, and Welfare. Overview for those using high cost medical care (in Japanese). Tokyo: Ministry of Health, Labor, and Welfare; 2018."},{"key":"e_1_3_2_10_1","volume-title":"Survey on the salary structure \u2013 report summary of year 2017","author":"Ministry of Health, Labor, and Welfare.","year":"2017","unstructured":"Ministry of Health, Labor, and Welfare. Survey on the salary structure \u2013 report summary of year 2017 (in Japanese). Tokyo: Ministry of Health, Labor, and Welfare; 2017."},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyt015"},{"key":"e_1_3_2_12_1","volume-title":"Patient mindscape (APM) survey","author":"INTAGE Healthcare Inc.","year":"2019","unstructured":"INTAGE Healthcare Inc. Patient mindscape (APM) survey. Tokyo: INTAGE Healthcare Inc.; 2019."},{"key":"e_1_3_2_13_1","volume-title":". Research on inclusion of health economics in treatment guidelines","author":"Shiroiwa T","year":"2016","unstructured":"Shiroiwa T, Tsutani K. Research on inclusion of health economics in treatment guidelines (in Japanese). Tokyo (Japan): Health Labor Sciences Research Grant, Ministry of Health, Labor and Welfare; 2016."},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2017.12.012"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2015.1031732"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2016.77"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ad.2016.09.010"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0207993"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajco.12354"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.1080\/14737167.2018.1467270"},{"key":"e_1_3_2_21_1","first-page":"616","article-title":"Review of colorectal cancer cases based on their route of detection (in Japanese","volume":"30","author":"Kawamura M","year":"2015","unstructured":"Kawamura M, Takao H, Okumura M, et\u00a0al. Review of colorectal cancer cases based on their route of detection (in Japanese). Ningen Dock. 2015;30:616\u2013622.","journal-title":"Ningen Dock"},{"key":"e_1_3_2_22_1","volume-title":"Dexamethasone listing","author":"KEGG Medicus.","unstructured":"KEGG Medicus. Dexamethasone listing. Kyoto: KEGG Medicus."},{"key":"e_1_3_2_23_1","volume-title":"Lenalidomide listing","author":"KEGG Medicus.","unstructured":"KEGG Medicus. Lenalidomide listing. Kyoto: KEGG Medicus."},{"key":"e_1_3_2_24_1","unstructured":"KEGG Medicus. Daratumumab listing. Kyoto: KEGG Medicus."},{"key":"e_1_3_2_25_1","volume-title":"Dasatinib Listing","author":"KEGG Medicus.","unstructured":"KEGG Medicus. Dasatinib Listing. Kyoto: KEGG Medicus."},{"key":"e_1_3_2_26_1","volume-title":"Sprycel 20mg\/50mg usage survey report","author":"Bristol Meyers Squibb KK","year":"2015","unstructured":"Bristol Meyers Squibb KK. Sprycel 20mg\/50mg usage survey report. Tokyo: Bristol Meyers Squibb KK; 2015."},{"key":"e_1_3_2_27_1","volume-title":"2018 Physician survey report","author":"Ministry of Health, Labor, and Welfare","year":"2018","unstructured":"Ministry of Health, Labor, and Welfare. 2018 Physician survey report. Tokyo: Ministry of Health, Labor, and Welfare; 2018."},{"key":"e_1_3_2_28_1","volume-title":"2018 Survey of medical institutions report","author":"Ministry of Health, Labor, and Welfare","year":"2018","unstructured":"Ministry of Health, Labor, and Welfare. 2018 Survey of medical institutions report. Tokyo: Ministry of Health, Labor, and Welfare; 2018."},{"key":"e_1_3_2_29_1","volume-title":"Cancer base hospital listing","author":"Ministry of Health, Labor, and Welfare.","year":"2018","unstructured":"Ministry of Health, Labor, and Welfare. Cancer base hospital listing. Tokyo: Ministry of Health, Labor, and Welfare; 2018."},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-017-2330-1"},{"key":"e_1_3_2_31_1","unstructured":"CancerMPact\u00ae. 2020 [cited 2020 Apr 24]. Available from: Cerner EnvizaSM\/Synix Inc.: synix.co.jp\/cancermpact (Unauthorized reproduction prohibited)."}],"container-title":["Journal of Medical Economics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13696998.2022.2062951","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T11:12:30Z","timestamp":1729163550000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13696998.2022.2062951"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,2]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12,31]]}},"alternative-id":["10.1080\/13696998.2022.2062951"],"URL":"https:\/\/doi.org\/10.1080\/13696998.2022.2062951","relation":{},"ISSN":["1369-6998","1941-837X"],"issn-type":[{"value":"1369-6998","type":"print"},{"value":"1941-837X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-01-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-03-26","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-04-04","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}